These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4727310)

  • 1. Xanthoma-like skin lesions as a presenting feature in primary systemic amyloidosis.
    Chapman RS; Neville EA; Lawson JW
    Br J Clin Pract; 1973 Jul; 27(7):271-3. PubMed ID: 4727310
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of diffuse plane normolipaemic xanthoma and amyloidosis in a patient with monoclonal gammopathy.
    Buezo GF; Porras JI; Fraga J; Sanchez E; Aragües M; Daudén E
    Br J Dermatol; 1996 Sep; 135(3):460-2. PubMed ID: 8949445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary systemic amyloidosis presenting with demyelinating features.
    Gutierrez A; Turkewitz LJ; Correa H; England JD
    Neurol Neurophysiol Neurosci; 2006 Dec; ():6. PubMed ID: 17260083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthomatous lesions: atypical presentation of primary systemic amyloidosis.
    Simão dos Santos B; Diniz A; Estrella R; Rochael M
    Int J Dermatol; 2013 Nov; 52(11):1403-5. PubMed ID: 24164157
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic AL-kiv amyloidosis presenting as giant hepatomegaly.
    Pras M; Frangione B; Franklin EC; Gafni J
    Isr J Med Sci; 1982 Aug; 18(8):866-9. PubMed ID: 7118533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous amyloidosis.
    Westermark P; Ohman S; Domar M; Sletten K
    Arch Dermatol; 1981 Dec; 117(12):782-4. PubMed ID: 7032426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive haemorrhagic-bullous skin manifestation of systemic AA-amyloidosis associated with IgGlambda-myeloma.
    Grundmann JU; Bonnekoh B; Gollnick H
    Eur J Dermatol; 2000 Mar; 10(2):139-42. PubMed ID: 10694315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin in amyloidosis. (A case report on primary systemic amyloidosis with skin involvement and a review of skin manifestations of amyloidosis).
    Desai SC; Sethi NC; Mehta RS
    J Assoc Physicians India; 1966 Jan; 14(1):1-7. PubMed ID: 4159567
    [No Abstract]   [Full Text] [Related]  

  • 10. [Purpura: primary systemic amyloidosis manifestation].
    Lestre S; Gonçalves A; João A; Ferreira A; Apetato M
    Acta Med Port; 2009; 22(3):307-12. PubMed ID: 19686633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary systemic amyloidosis presenting as extreme hyperlipidaemia with tendon xanthomas.
    Levy Y; Magill PJ; Miller NE; Coltart J; Lewis B
    Br Med J (Clin Res Ed); 1981 Sep; 283(6293):699-700. PubMed ID: 6793131
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual cutaneous findings in primary systemic amyloidosis. Report of a case.
    Noojin RO; Arrington TS
    Arch Dermatol; 1965 Aug; 92(2):157-9. PubMed ID: 11850917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic amyloidosis presenting recurrent abdominal pain and diarrhea].
    Kanahisa T; Matsuo E; Tanaka K; Sakai N; Sumiyoshi A
    Rinsho Byori; 1968 Apr; 16(4):386-92. PubMed ID: 5748616
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intestinal pseudo-obstruction in primary amyloidosis of the intestinal tract].
    Rewitzer H; Wegmann W; Stotz R
    Schweiz Med Wochenschr; 1984 Dec; 114(50):1886-90. PubMed ID: 6515390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cutaneous amyloidoses. II. Systemic forms.
    Brownstein MH; Helwig EB
    Arch Dermatol; 1970 Jul; 102(1):20-8. PubMed ID: 5497171
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
    Hind CR; Tennent GA; Evans DJ; Pepys MB
    J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement in systemic amyloidosis.
    Browning M; Banks R; Tribe C; Bacon P; Hollingworth P; Kingswood C; Poulding J; Harrison P; Mackenzie JC
    Proc Eur Dial Transplant Assoc; 1983; 20():595-602. PubMed ID: 6657678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucocutaneous manifestations of amyloidosis].
    Timmer-de Mik L; van der Waal RI; Canninga-van Dijk MR; Dikland WJ; Rodenburg CJ; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2007 Sep; 151(37):2032-8. PubMed ID: 17929711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis is frequently undetected in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M
    Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits.
    Rekhtman N; Hash KS; Moresi JM
    Br J Dermatol; 2006 Apr; 154(4):751-4. PubMed ID: 16536823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.